NLTX - Neoleukin Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - NLTX (1404644)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
5 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2023-08-15
NLTXBaker Bros. Advisors LPDir, 10%P - Purchase$0.64+2,285,3425,617,469+69%+$1,463,487
D
2023-08-11
NLTXSmith Sean MichaelInterim CFO, Prin Acct OffS - Sale+OE$0.62-1,32321,637-6%-$818
D
2023-04-03
NLTXPatel PritiFormer Chief Medical OfficerS - Sale+OE$0.69-3,76937,313-9%-$2,608
D
2023-02-02
NLTXSmith Sean MichaelPrincipal Accounting OfficerS - Sale+OE$0.60-3,31615,960-17%-$1,980
D
2023-02-02
NLTXPatel PritiChief Medical OfficerS - Sale+OE$0.60-14,38031,082-32%-$8,588

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top